Clinical Trials on Immune Deficiency Disease in China

Total 32311 results

Chinese PLA General Hospital

Recruiting

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation

China
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Severe Asthma

China
Rush University Medical Center
People's Liberation Army General Hospital

Completed

The Role of Gas Flow in Transnasal Pulmonary Aerosol Delivery: A Double-blinded, Randomized Controlled Trial

COPD Asthma

China
Stallergenes Greer

Completed

A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Allergy

China
Peking Union Medical College

Unknown

Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model

Organoid

China
Chinese PLA General Hospital

Active, not recruiting

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation

China
Wuhan Union Hospital, China
The First Affiliated Hospital of Nanchang University; The Third Xiangya Hospital... and other collaborators

Unknown

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) ((ITP;rhTPO))

Primary Immune Thrombocytopenia

China
National Center for AIDS/STD Control and Prevention...
Gilead Sciences

Completed

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Hiv

China
Shandong University

Recruiting

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

ITP - Immune Thrombocytopenia

China
Shandong University

Recruiting

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Primary Immune Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

HIV-1 Infection

China
Affiliated Hospital to Academy of Military Medical...
Peking University; Capital Medical University

Unknown

Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

HIV-1-infection

China
Peking University People's Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Unknown

Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation (hAECs-GVHD)

Acute-graft-versus-host Disease

China
Peking University People's Hospital

Unknown

Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation

Acute Graft-versus-host Disease

China
Sichuan University

Unknown

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

MDS | Leukemia, Acute

China
Ruijin Hospital

Recruiting

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Antiphospholipid Syndrome (APS)

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Trial of HBM9378 in Healthy Chinese Subjects

Asthma

China
GlaxoSmithKline

Completed

Study of GSK3511294 in Healthy Chinese Participants

Asthma

China
Keymed Biosciences Co.Ltd

Completed

Single Ascending Dose Study of CM326 in Healthy Volunteers

Asthma

China
Fujian Medical University

Unknown

MSC for Severe aGVHD

Steroid-resistant Severe aGVHD

China
Peking Union Medical College Hospital

Recruiting

Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT

Arthritis

China
First Affiliated Hospital of Suzhou Medical College

Completed

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic Purpura

China
Cancer Institute and Hospital, Chinese Academy...
307 Hospital of PLA; Chinese PLA General Hospital; Zhejiang University; Peking...

Unknown

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease (MSCsTcGVHD)

Chronic Graft Versus Host Disease

China
The Second Hospital of Shandong University

Recruiting

Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw

Surgery | Aspirin Sensitivity

China
Wuhan Union Hospital, China

Completed

Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI

Percutaneous Coronary Intervention | NLRP3 | hsCRP

China
Second Affiliated Hospital of Wenzhou Medical University

Unknown

Epidemiological Investigation and Cohort Study on Food Allergy in Children Aged 3 to 6 Years in Wenzhou and Taizhou Urban Areas

Food Hypersensitivity

China
Sinocelltech Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

Clinical Study of 1A46 Drug Substance

Advanced Malignancies

China
Southwest Hospital, China

Unknown

A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies

Lymphoma | Leukemia

China
Shanghai Tongji Hospital, Tongji University School...

Unknown

CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy

Lymphoma | Leukemia

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL95 in Advanced Malignancies.

Advanced Malignancies

China
Akeso

Completed

A Phase 1 Dose Escalation and Expansion Study of AK117

Neoplasms Malignant

China
Nanjing Medical University

Completed

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)

Immune Checkpoint Inhibitor | Endocrine Toxicity

China
Guangdong Provincial People's Hospital
Sun Yat-sen University

Unknown

Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease

Graft Versus Host Disease

China
Shenzhen People's Hospital

Recruiting

Denosumab vs Alendronate After Vertebroplasty

Denosumab Allergy

China
Centre for Immunology & Infection
The University of Hong Kong; Institut Pasteur

Completed

The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)

Healthy | Immune System and Related Disorders

China
Shenzhen People's Hospital

Withdrawn

Denosumab and Screw Fixation for Osteoporotic Compression Fracture

Denosumab Allergy

China
First Affiliated Hospital of Suzhou Medical College

Completed

Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic Purpura

China
Yale University
National Institute of Nursing Research (NINR); Beijing Ditan Hospital; Shanghai...

Completed

Self- and Family-management Intervention in HIV+ Chinese Women

Hiv

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT (ATG/PTCy)

Prophylaxis | Graft-versus-host-disease

China
Aier School of Ophthalmology, Central South University

Recruiting

Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens

Cataract | Myopia | Intraocular Lens

China
Shenzhen Geno-Immune Medical Institute
Guilin Hospital of Chinese Traditional and Western Medicine

Recruiting

CAR-T Cells Targeting Autoimmune Diseases

Autoimmune Diseases

China
Peking Union Medical College Hospital

Unknown

TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial

Multicentric Castleman Disease

China
United BioPharma

Withdrawn

To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults

HIV-1 Infection

China
Peking Union Medical College Hospital
National Key Technologies R&D Program for the 13th Five-year Plan; National... and other collaborators

Completed

Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

HIV-1-infection

China
Peking Union Medical College

Unknown

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

AIDS/HIV PROBLEM

China
Beijing 302 Hospital
Tsinghua University

Unknown

Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection (TCTIWHI)

HIV-1

China
Shanghai Public Health Clinical Center
Fudan University; Shanghai Xinhao Biological Technology Co., Ltd.

Unknown

Euphorbia Kansui and HIV/AIDS Functional Cure

HIV-1-infection

China
Shanxi Kangbao Biological Product Co., Ltd.
Institute of Pathogen Biology, Chinese Academy of Medical Sciences

Recruiting

Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.

HIV

China
Peking University First Hospital
Peking University People's Hospital; Peking University Third Hospital; Peking... and other collaborators

Unknown

Combination Therapy Prevents the Relapse of RA

Recurrence (Disease Attribute)

China

Clinical Trials on Immune Deficiency Disease in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations